Literature DB >> 22521462

Mutant HSPB1 overexpression in neurons is sufficient to cause age-related motor neuronopathy in mice.

Amit K Srivastava1, Samantha R Renusch, Nicole E Naiman, Shuping Gu, Amita Sneh, W David Arnold, Zarife Sahenk, Stephen J Kolb.   

Abstract

The small heat shock protein HSPB1 is a multifunctional, α-crystallin-based protein that has been shown to be neuroprotective in animal models of motor neuron disease and peripheral nerve injury. Missense mutations in HSPB1 result in axonal Charcot-Marie-Tooth disease with minimal sensory involvement (CMT2F) and distal hereditary motor neuropathy type 2 (dHMN-II). These disorders are characterized by a selective loss of motor axons in peripheral nerve resulting in distal muscle weakness and often severe disability. To investigate the pathogenic mechanisms of HSPB1 mutations in motor neurons in vivo, we have developed and characterized transgenic PrP-HSPB1 and PrP-HSPB1(R136W) mice. These mice express the human HSPB1 protein throughout the nervous system including in axons of peripheral nerve. Although both mouse strains lacked obvious motor deficits, the PrP-HSPB1(R136W) mice developed an age-dependent motor axonopathy. Mutant mice showed axonal pathology in spinal cord and peripheral nerve with evidence of impaired neurofilament cytoskeleton, associated with organelle accumulation. Accompanying these findings, increases in the number of Schmidt-Lanterman incisures, as evidence of impaired axon-Schwann cell interactions, were present. These observations suggest that overexpression of HSPB1(R136W) in neurons is sufficient to cause pathological and electrophysiological changes in mice that are seen in patients with hereditary motor neuropathy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521462      PMCID: PMC3367118          DOI: 10.1016/j.nbd.2012.03.035

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  48 in total

1.  Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.

Authors:  Francesco Paolo Di Giorgio; Monica A Carrasco; Michelle C Siao; Tom Maniatis; Kevin Eggan
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

Review 2.  Diagnosis, natural history, and management of Charcot-Marie-Tooth disease.

Authors:  Davide Pareyson; Chiara Marchesi
Journal:  Lancet Neurol       Date:  2009-07       Impact factor: 44.182

3.  Abnormal small heat shock protein interactions involving neuropathy-associated HSP22 (HSPB8) mutants.

Authors:  Jean-Marc Fontaine; Xiankui Sun; Adam D Hoppe; Stephanie Simon; Patrick Vicart; Michael J Welsh; Rainer Benndorf
Journal:  FASEB J       Date:  2006-08-25       Impact factor: 5.191

4.  Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.

Authors:  Makiko Nagai; Diane B Re; Tetsuya Nagata; Alcmène Chalazonitis; Thomas M Jessell; Hynek Wichterle; Serge Przedborski
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

5.  Asymmetrical late onset motor neuropathy associated with a novel mutation in the small heat shock protein HSPB1 (HSP27).

Authors:  P A James; J Rankin; K Talbot
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04       Impact factor: 10.154

6.  Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Jonathan D Edwards; Arthur H M Burghes
Journal:  Neurobiol Dis       Date:  2007-05-05       Impact factor: 5.996

7.  Insights into function and regulation of small heat shock protein 25 (HSPB1) in a mouse model with targeted gene disruption.

Authors:  Lei Huang; Jin-Na Min; Shane Masters; Nahid F Mivechi; Demetrius Moskophidis
Journal:  Genesis       Date:  2007-08       Impact factor: 2.487

8.  The protective effects of Achyranthes bidentata polypeptides in an experimental model of mouse sciatic nerve crush injury.

Authors:  Ying Yuan; Hongmei Shen; Jian Yao; Nan Hu; Fei Ding; Xiaosong Gu
Journal:  Brain Res Bull       Date:  2010-01-15       Impact factor: 4.077

Review 9.  Diagnosis and new treatments in genetic neuropathies.

Authors:  M M Reilly; M E Shy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-12       Impact factor: 10.154

10.  Phenotype of Charcot-Marie-Tooth disease Type 2.

Authors:  H M E Bienfait; F Baas; J H T M Koelman; R J de Haan; B G M van Engelen; A A W M Gabreëls-Festen; B W Ongerboer de Visser; F Meggouh; M A J Weterman; P De Jonghe; V Timmerman; M de Visser
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

View more
  20 in total

Review 1.  Small heat shock proteins in ageing and age-related diseases.

Authors:  Nikolaos Charmpilas; Emmanouil Kyriakakis; Nektarios Tavernarakis
Journal:  Cell Stress Chaperones       Date:  2017-01-10       Impact factor: 3.667

2.  Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F.

Authors:  Nicholas U Schwartz; Ryan W Linzer; Jean-Philip Truman; Mikhail Gurevich; Yusuf A Hannun; Can E Senkal; Lina M Obeid
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

3.  In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration.

Authors:  Eveliina Pollari; Robert Prior; Wim Robberecht; Philip Van Damme; Ludo Van Den Bosch
Journal:  J Vis Exp       Date:  2018-06-15       Impact factor: 1.355

4.  HSPB1 mutations causing hereditary neuropathy in humans disrupt non-cell autonomous protection of motor neurons.

Authors:  Patrick L Heilman; SungWon Song; Carlos J Miranda; Kathrin Meyer; Amit K Srivastava; Amy Knapp; Christopher G Wier; Brian K Kaspar; Stephen J Kolb
Journal:  Exp Neurol       Date:  2017-08-07       Impact factor: 5.330

Review 5.  Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Sabita Kawan; Bjarne Udd
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

Review 6.  Mutations in HspB1 and hereditary neuropathies.

Authors:  Lydia K Muranova; Maria V Sudnitsyna; Sergei V Strelkov; Nikolai B Gusev
Journal:  Cell Stress Chaperones       Date:  2020-04-16       Impact factor: 3.667

7.  HspB1 silences translation of PDZ-RhoGEF by enhancing miR-20a and miR-128 expression to promote neurite extension.

Authors:  Xiankui Sun; Zhigang Zhou; David J Fink; Marina Mata
Journal:  Mol Cell Neurosci       Date:  2013-10-16       Impact factor: 4.314

8.  Overexpression of mutant HSP27 causes axonal neuropathy in mice.

Authors:  Jinho Lee; Sung-Chul Jung; Jaesoon Joo; Yu-Ri Choi; Hyo Won Moon; Geon Kwak; Ha Kyung Yeo; Ji-Su Lee; Hye-Jee Ahn; Namhee Jung; Sunhee Hwang; Jingeun Rheey; So-Youn Woo; Ji Yon Kim; Young Bin Hong; Byung-Ok Choi
Journal:  J Biomed Sci       Date:  2015-06-19       Impact factor: 8.410

9.  Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of Concept.

Authors:  W David Arnold; Paul N Porensky; Vicki L McGovern; Chitra C Iyer; Sandra Duque; Xiaobai Li; Kathrin Meyer; Leah Schmelzer; Brian K Kaspar; Stephen J Kolb; John T Kissel; Arthur H M Burghes
Journal:  Ann Clin Transl Neurol       Date:  2014-01-01       Impact factor: 4.511

10.  Muscle contractility dysfunction precedes loss of motor unit connectivity in SOD1(G93A) mice.

Authors:  Christopher G Wier; Alexander E Crum; Anthony B Reynolds; Chitra C Iyer; Deepti Chugh; Marilly S Palettas; Patrick L Heilman; David M Kline; W David Arnold; Stephen J Kolb
Journal:  Muscle Nerve       Date:  2018-12-21       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.